This controlled document shall not be copied in part or whole without the express permission of the author or the author s representative.

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "This controlled document shall not be copied in part or whole without the express permission of the author or the author s representative."

Transcription

1

2 This document is also available in large print and other formats and languages, upon request. Please call NHS Grampian Corporate Communications on (01224) or (01224) This controlled document shall not be copied in part or whole without the express permission of the author or the author s representative. Title: Instructions for using the In-Patient Warfarin Prescription Chart in NHS Grampian Unique Identifier: NHSG/Inst/WPC/MGPG899 Replaces: NHSG/Inst/WPC/MGPG618, Version 1.1 Lead Author/Coordinator: Subject (as per document registration categories): Key word(s): Policy, Protocol, Procedure or Process Document: Document application: Purpose/description: Group/Individual responsible for this document: Policy statement: Principal Pharmacist (Clinical), Aberdeen Royal Infirmary Prescribing and prescription Warfarin, instructions, prescribing, administration, medicines, in-patient, prescription, chart Guidance Whole of NHS Grampian To promote the safe use of the In-Patient Warfarin Prescription Chart. Records Standards Group It is the responsibility of individual healthcare professionals and their line managers to ensure that they work with the terms laid down in this guidance and to ensure that staff are working to the most up to date guidance. By doing so, the quality of the services offered will be maintained, and the chances of staff making erroneous decisions which may affect patient, staff or visitor safety and comfort will be reduced. Supervisory staff at all levels must ensure that healthcare professionals using this guidance act within their own level of competence. UNCONTROLLED WHEN PRINTED Review Date: August 2020 Identifier: NHSG/Inst/WPC/MGPG899 - i -

3 Responsibilities for ensuring registration of this document on the NHS Grampian Information/ Document Silo: Lead Author/Coordinator: Physical location of the original of this document: Job title of creator of this document: Job/group title of those who have control over this document: Pharmacist, Pharmacy and Medicines Directorate Principal Pharmacist (Clinical), Aberdeen Royal Infirmary Pharmacy Office, Aberdeen Royal Infirmary Principal Pharmacist (Clinical), Aberdeen Royal Infirmary Records Standards Group Responsibilities for disseminating document as per distribution list: Lead Author/Co-ordinator Principal Pharmacist (Clinical), Aberdeen Royal Infirmary Responsibilities for implementation: Organisational: Hospital/Interface services: Operational Management Unit: Departmental: Area: Review: Acute Sector Operational Management Team and Acute Sector General Manager Assistant General Managers and Group Clinical Directors Unit Operational Managers Clinical Leads Line Managers This policy will be reviewed in two years or sooner if current treatment recommendations change Responsibilities for review of this document: Lead Author/Coordinator: Review date: Principal Pharmacist (Clinical), Aberdeen Royal Infirmary Review 3 yearly. Any significant changes in evidence will result in earlier alteration. Revision History: Revision Date Previous Revision Date Summary of Changes (Descriptive summary of the changes made) Changes Marked* (Identify page numbers and section heading ) August 2017 November yearly update. August 2017 November grammatical errors. Introduction (page 1) August 2017 November 2013 Section headings added. Throughout document UNCONTROLLED WHEN PRINTED Review Date: August 2020 Identifier: NHSG/Inst/WPC/MGPG899 - ii -

4 August 2017 November 2013 Minor amendments to prescription examples in line with updated Instructions for NHS Grampian Staff on the Prescribing and Administration of Medicines Using the NHS Grampian Prescription and Administration Record. All examples updated UNCONTROLLED WHEN PRINTED Review Date: August 2020 Identifier: NHSG/Inst/WPC/MGPG899 - iii -

5 Instructions For Using The In-Patient Warfarin Prescription Chart In NHS Grampian Contents Page No: 1. Introduction Prescribing Guidance Prescription and Administration Record (PAR) In-Patient Warfarin Prescription Chart Discontinuing Warfarin Therapy Completing Discharge Checklist Warfarin Therapy Started Prior to Admission (Example 7) Warfarin Therapy Started During Admission (Example 8)... 7 Appendix A: In-Patient Warfarin Prescription Chart... 8 Appendix B: In-Patient Warfarin Prescription Chart (Long Stay) UNCONTROLLED WHEN PRINTED Review Date: August 2020 Identifier: NHSG/Inst/WPC/MGPG

6 Instructions for Using the In-Patient Warfarin Prescription Chart in NHS Grampian 1. Introduction This chart is intended to be used only for the prescription of warfarin to in-patients. This prescription chart requires that an entry be made detailing the warfarin dose for each day. This prescription chart should always be used in conjunction with a Prescription and Administration Record (PAR), i.e. main kardex. As with all prescription charts in NHS Grampian, this chart should be completed legibly in black ink and in BLOCK LETTERS. Note: There are 2 versions of the warfarin in-patient prescription chart, the standard version (Appendix A) and the long-stay version (Appendix B). Both charts should be completed using the following instructions. 2. Prescribing Guidance 2.1. Prescription and Administration Record (PAR) 1) Complete all necessary biographical details on the Prescription and Administration Record (PAR) (if not already done) according to NHS Grampian guidelines. Ensure the Known Medicine Allergies/Sensitivities box has been completed on the PAR and that there is no record that the patient has sensitivity to the drug which is to be prescribed. 2) In the Other Medicine Charts or Treatment Plans in Use section, ensure that the box is ticked indicating that the In-Patient Warfarin Prescription Chart ( Oral anticoagulation prescription sheet ) is in use (Example 1). Example 1: Other Medicine Charts or Treatment Plans in Use Entry UNCONTROLLED WHEN PRINTED Review Date: August 2020 Identifier: NHSG/Inst/WPC/MGPG

7 3) Prescribe warfarin in the regular therapy section of the PAR (Example 2). Example 2: Regular Therapy Entry 2.2. In-Patient Warfarin Prescription Chart (See Appendix A standard version, Appendix B long stay version and Examples 3 and 4 below) 1) Complete the biographical details at the top of the In-Patient Warfarin Prescription Chart Patient s name: Full name in BLOCK LETTERS. Date of birth: Written as, e.g CHI number: Patient s community health index number in full, e.g A printed patient label may be used for the above. Ward: Ward name should be written in full. Hospital: Abbreviations can be used, e.g. ARI. Consultant: Surname should be written in full. Allergies: Complete the allergy box/boxes if no allergies /sensitivities write NKDA in box 1. Date of admission. Prescription number record chronologically. 2) Indication select the indication for the patient being prescribed warfarin (tick box); if the indication is not listed state under other. 3) Warfarin on admission box complete if patient was taking warfarin on admission to hospital and complete the dose and intended duration. 4) New warfarin therapy box if warfarin therapy is new, select one of the regimes from the reverse of the chart and enter fast or slow, as appropriate into the box. In some specialist areas the senior doctor may specify a regime which is different from the fast or slow initiation schedules, in this case leave the box blank. UNCONTROLLED WHEN PRINTED Review Date: August 2020 Identifier: NHSG/Inst/WPC/MGPG

8 5) Concurrent medicines box if the patient is on any other medicine known to interact with warfarin (see current version of BNF), then please state here and specify likely effect. 6) Warfarin prescribing please refer to dosing regime selected if new therapy, otherwise clinical decisions on dosing should be made using the INR results and taking into account the warfarin dose on admission. 7) For each day s medication prescribed, the prescriber must complete: the date the INR result when checked the medicine, i.e. warfarin the dose in mg or withhold if no dose to be administered the time, usually 1800 a signature/print name. 8) In the Dose column, write the required dose to be given at that time. The smallest dose increments are 500micrograms (doses less than 1mg should be prescribed in micrograms do not abbreviate). 9) When administering the medication the nurse(s) involved should follow NHS Grampian guidelines for medicines administration and sign the Administered By section on the In-Patient Warfarin Prescription Chart. 10) If a dose is not administered, write an explanation in Administered By column, e.g. patient refused dose at Example 3: Patient Admitted on Warfarin 3mg daily Life-long Amiodarone increases INR 1/9/ Warfarin 3mg 1800 A Doctor A. DOCTOR A Nurse 2/9/ Warfarin 3mg 1800 A Doctor A. DOCTOR A Nurse UNCONTROLLED WHEN PRINTED Review Date: August 2020 Identifier: NHSG/Inst/WPC/MGPG

9 Example 4: New Warfarin Fast 1/9/17 Warfarin 10mg 1800 A Doctor A. DOCTOR A Nurse 2/9/ Warfarin 10mg 1800 A Doctor A. DOCTOR A Nurse 3/9/ Warfarin 10mg 1800 A Doctor A. DOCTOR A Nurse 2.3. Discontinuing Warfarin Therapy 1) When warfarin therapy is discontinued, two diagonal lines should be drawn across the administration record box and the date of discontinuation and prescriber s signature should be added. 2) The medication must also be discontinued on the Prescription and Administration Record (PAR) (Examples 5 and 6). Example 5: Discontinuation of Other Medicine Charts or Treatment Plans in Use Entry UNCONTROLLED WHEN PRINTED Review Date: August 2020 Identifier: NHSG/Inst/WPC/MGPG

10 Example 6: Discontinuation of Regular Therapy Entry 3) The In-Patient Warfarin Prescription Chart should be filed in section D of the patient s medical notes. 3. Completing Discharge Checklist The discharge checklist should be completed on or before discharge. Whilst some parts of the checklist can be completed during the admission, the whole section should be reviewed on discharge by the healthcare professional discharging the patient Warfarin Therapy Started Prior to Admission (Example 7) 1) All patients must be given an anticoagulant pack if they haven t received one in the past. 2) The recording (yellow) booklet must be completed detailing the doses given during admission and the INRs recorded. 3) The patient/relative/carer must be aware of the doses to be taken and when and where the next INR check needs to be done. Example 7: Warfarin Therapy Started Prior to Admission Brought book in Done previously Yes 1/9/17 Yes 1/9/17 N/A INR check 3/9/17 GP A Doctor A Pharmacist A Nurse UNCONTROLLED WHEN PRINTED Review Date: August 2020 Identifier: NHSG/Inst/WPC/MGPG

11 3.2. Warfarin Therapy Started During Admission (Example 8) 1) All patients must be given an anticoagulant pack containing information on warfarin and a recording book and alert card. 2) They should receive full counselling on this new treatment. 3) The recording (yellow) booklet must be completed in full detailing the doses given since therapy started and the INRs recorded. 4) The patient/relative/carer must be aware of the doses to be taken and when and where the next INR check needs to be done. 5) The patient s GP surgery must be contacted to ensure they are aware of a new patient on warfarin. Example 8: Warfarin Therapy Started During Admission Yes 1/9/17 Yes 3/9/17 Yes 5/9/17 Yes 5/9/17 Yes 5/9/17 INR check 7/9/17 GP A Pharmacist A Pharmacist A Doctor A Nurse A Doctor A Nurse UNCONTROLLED WHEN PRINTED Review Date: August 2020 Identifier: NHSG/Inst/WPC/MGPG

12 Appendix A: In-Patient Warfarin Prescription Chart UNCONTROLLED WHEN PRINTED Review Date: August 2020 Identifier: NHSG/Inst/WPC/MGPG

13 Appendix A (continued): In-Patient Warfarin Prescription Chart UNCONTROLLED WHEN PRINTED Review Date: August 2020 Identifier: NHSG/Inst/WPC/MGPG

14 Appendix B: In-Patient Warfarin Prescription Chart (Long Stay) UNCONTROLLED WHEN PRINTED Review Date: August 2020 Identifier: NHSG/Inst/WPC/MGPG

15 Appendix B (continued): In-Patient Warfarin Prescription Chart (Long Stay) UNCONTROLLED WHEN PRINTED Review Date: August 2020 Identifier: NHSG/Inst/WPC/MGPG

16 Appendix B (continued): In-Patient Warfarin Prescription Chart (Long Stay) UNCONTROLLED WHEN PRINTED Review Date: August 2020 Identifier: NHSG/Inst/WPC/MGPG

NHS Grampian Medicines Reconciliation Protocol. Organisational: Area:

NHS Grampian Medicines Reconciliation Protocol. Organisational: Area: Title: Unique Identifier: NHS Grampian Medicines Reconciliation Protocol NHSG/Guid/Med_RecMGPG711 Replaces: N/A New document Across NHS Boards Organisation Wide Yes Directorate Clinical Service Sub Department

More information

Consultation Group: See relevant page in the PGD. Review Date: October 2016

Consultation Group: See relevant page in the PGD. Review Date: October 2016 Patient Group Direction For The Administration Of Adrenaline (Epinephrine) By Trained Nurses In The Management Of Cardiac Arrest In The Medical High Dependency Unit/Coronary Care Unit (MHDU/CCU) Working

More information

The Prescribing, Monitoring and Administration of Depot / Long Acting IM Medication within Community Mental Health Services

The Prescribing, Monitoring and Administration of Depot / Long Acting IM Medication within Community Mental Health Services Standard Operating Procedure 2 (SOP 2) The Prescribing, Monitoring and Administration of Depot / Long Acting IM Medication within Community Mental Health Services Why we have a procedure? Black Country

More information

Consultation Group: See relevant page in the PGD. Review Date: October 2015

Consultation Group: See relevant page in the PGD. Review Date: October 2015 Patient Group Direction For The Supply Of Trimethoprim For The Treatment Of Women With Uncomplicated Urinary Tract Infections By Nurses And Pharmacists Working Within NHS Grampian Community Pharmacies

More information

Storyboard Submission NHS Wales Awards Title Improving Patient Safety How ABHB Ward Pharmacists Monitor Elevated INRs

Storyboard Submission NHS Wales Awards Title Improving Patient Safety How ABHB Ward Pharmacists Monitor Elevated INRs Storyboard Submission 1. Title Improving Patient Safety How ABHB Ward Pharmacists Monitor Elevated 2. Brief Outline of Context As part of the 1000 Lives Plus initiative, ward pharmacists throughout ABHB

More information

Administering Medicine Policy

Administering Medicine Policy Administering Medicine Policy Date Agreed: November 2015 Review Date: November 2016 Hove Junior School is committed to safeguarding and promoting the welfare of children and young people and expects all

More information

NPSA Alert 03: Reducing the harm caused by oral Methotrexate. Implementation Progress Report July Learning and Sharing

NPSA Alert 03: Reducing the harm caused by oral Methotrexate. Implementation Progress Report July Learning and Sharing NPSA Alert 03: Reducing the harm caused by oral Methotrexate Implementation Progress Report July 2006 Learning and Sharing CONTENTS Page 1 Background 3 2 Findings 4 Appendix 1 Summary of responses 6 Appendix

More information

Medicines Reconciliation Standard Operating Procedures

Medicines Reconciliation Standard Operating Procedures Creator Sam Carvell, Amber Wynne, Sue Coppack Version 1 Review Date Medicines Reconciliation Standard Operating Procedures Purpose of SOP This standard operating procedure (SOP) provides a framework for

More information

COMMUNITY PHARMACY MINOR AILMENTS SERVICE

COMMUNITY PHARMACY MINOR AILMENTS SERVICE COMMUNITY PHARMACY MINOR AILMENTS SERVICE SUPPORTING SELF-CARE OCTOBER 2010 CONTENTS Index Page No 1 Introduction 3 2 Service Specification 4 3 Consultation Procedure 7 4 Re-ordering Documentation 10 Appendices

More information

MEDICINES RECONCILIATION GUIDELINE Document Reference

MEDICINES RECONCILIATION GUIDELINE Document Reference MEDICINES RECONCILIATION GUIDELINE Document Reference G358 Version Number 1.01 Author/Lead Job Title Jackie Stark Principle Pharmacist Clinical Services Date last reviewed, (this version) 29 November 2012

More information

OSCE demo Oral Structured Clinical Examination

OSCE demo Oral Structured Clinical Examination OSCE demo Oral Structured Clinical Examination Patient interview. ü Aim: Identify incorrect medications in medication list Physician discussion. ü Aim: Implement correct medication list Tommy Eriksson

More information

Medicines Governance Service to Care Homes (Care Home Service)

Medicines Governance Service to Care Homes (Care Home Service) Medicines Governance Service to Care Homes (Care Home Service) Locally Enhanced Service Authors: Ruth Buchan, Senior Pharmacist Medicines Management 4th Floor F Mill Dean Clough Halifax HX3 5AX Tel-01422

More information

Improving compliance with oral methotrexate guidelines. Action for the NHS

Improving compliance with oral methotrexate guidelines. Action for the NHS Patient safety alert 13 Alert Immediate action Action Update Information request Ref: NPSA/2006/13 Improving compliance with oral methotrexate guidelines Oral methotrexate is a safe and effective medication

More information

INDEPENDENT NON-MEDICAL PRESCRIBING (NMPs) POLICY. Suffolk GP Federation Board

INDEPENDENT NON-MEDICAL PRESCRIBING (NMPs) POLICY. Suffolk GP Federation Board INDEPENDENT NON-MEDICAL PRESCRIBING (NMPs) POLICY Version: 1.0 Policy owner: Ratified by: Clinical Governance Lead Chief Executive Date approved: 28 th November 2014 Approved by: Suffolk GP Federation

More information

Medicine Management Policy

Medicine Management Policy INDEX Prescribing Page 2 Dispensing Page 3 Safe Administration Page 4 Problems & Errors Page 5 Self Administration Page 7 Safe Storage Page 8 Controlled Drugs Best Practice Procedure Page 9 Controlled

More information

Medicines Management in the Domiciliary Setting (Adults)

Medicines Management in the Domiciliary Setting (Adults) Medicines Management in the Domiciliary Setting (Adults) DOCUMENT NO: Lead author/initiator(s): (enter job titles) Developed by: (enter Team/Group etc.) Approved by: (enter management group/committee)

More information

Safer use of anticoagulants: the NPSA patient safety alert Steve Chaplin MSc, MRPharmS

Safer use of anticoagulants: the NPSA patient safety alert Steve Chaplin MSc, MRPharmS Safer use of anticoagulants: the NPSA patient safety alert Steve Chaplin MSc, MRPharmS Steve Chaplin describes the NPSA s anticoagulant patient safety alert and the measures it recommends for making the

More information

NHS Grampian Pharmaceutical Care Of Patients Receiving Treatment For Hepatitis C Service Specification

NHS Grampian Pharmaceutical Care Of Patients Receiving Treatment For Hepatitis C Service Specification NHS Grampian Pharmaceutical Care Of Patients Receiving Treatment For Hepatitis C Service Specification 1. Service Objectives 1.1 The specific objectives of the service to provide pharmaceutical care to

More information

Reducing Medication Errors: National Update

Reducing Medication Errors: National Update Reducing Medication Errors: National Update Ahmed Ameer Medication Safety Officer Ahmed.Ameer@NHS.net Safer Medication Practice & Medical Devices Team 27 th January 2015 Agenda 1. Development of the National

More information

Medicines Management in the Domiciliary Setting (Adults) Policy

Medicines Management in the Domiciliary Setting (Adults) Policy Medicines Management in the Domiciliary Setting (Adults) Policy DOCUMENT NO: DN230 Lead author/initiator(s): (enter job titles) Ann Darvill Principal Pharmacist Developed by: (enter Team/Group etc.) Domiciliary

More information

MANAGING THE INR CLINIC : IJN EXPERIENCE

MANAGING THE INR CLINIC : IJN EXPERIENCE MANAGING THE INR CLINIC : IJN EXPERIENCE Anticoagulation Workshop 21 st August 2015 KAMALESWARY ARUMUGAM PRINCIPAL PHARMACIST LEE LEE HO1 NURSE MENTOR, INR CLINIC HISTORY & OVERVIEW OF THE INR CLINIC HISTORY

More information

Transcribing Medicines for Adults Policy. Policy Register No:09076 Status: Public. NHSLA Risk Assessment standards

Transcribing Medicines for Adults Policy. Policy Register No:09076 Status: Public. NHSLA Risk Assessment standards ` Transcribing Medicines for Adults Policy Policy Register No:09076 Status: Public Developed in response to: Contributes to CQC Core Standard number: Dept of Health Medicines Regulations, NHSLA Risk Assessment

More information

Thoracic surgery medicines

Thoracic surgery medicines Addressograph Name: Date of birth: Hosp No: NHS No: Thoracic surgery medicines A patient s guide Medicine name Date last dose to be taken 1 Introduction This booklet is for patients waiting to have thoracic

More information

CLINICAL AUDIT. The Safe and Effective Use of Warfarin

CLINICAL AUDIT. The Safe and Effective Use of Warfarin CLINICAL AUDIT The Safe and Effective Use of Warfarin Valid to May 2019 bpac nz better medicin e Background Warfarin is the medicine most frequently associated with adverse drug reactions in New Zealand.

More information

MODULE 5: RECORDING & ERRORS

MODULE 5: RECORDING & ERRORS MODULE 5: RECORDING & ERRORS 5.1 Recording Administration Using a Medication Administration Record (MAR) Chart Care providers are responsible for maintaining an up-to-date record of medication administered.

More information

Medicines Reconciliation: Standard Operating Procedure

Medicines Reconciliation: Standard Operating Procedure Clinical Medicines Reconciliation: Standard Operating Procedure Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation

More information

Loading Dose Worksheet for Oral Amiodarone

Loading Dose Worksheet for Oral Amiodarone This applies to adult patients only Key: General Notes ED/MAU/SRU/Acute GP/Amb-Care GP/SWASFT In-patient wards Start Prescribe as per loading dose worksheet below End 1. Aim/Purpose of this Guideline 1.1.

More information

FOR MEDICINE ADMINISTRATION IN COMMUNITY NURSING

FOR MEDICINE ADMINISTRATION IN COMMUNITY NURSING STANDARD OPERATING PROCEDURE FOR MEDICINE ADMINISTRATION IN COMMUNITY NURSING Issue History Issue Version One Purpose of Issue/Description of Change To promote safe and effective medicine administration

More information

Standard Operating Procedure for When required (PRN) medicines in care homes

Standard Operating Procedure for When required (PRN) medicines in care homes Standard Operating Procedure for When required (PRN) medicines in care homes Introduction All health and social care organisations are responsible for ensuring the safe management of all medicines. This

More information

PROCEDURE FOR MEDICINES RECONCILIATION BY NURSING STAFF FOR PATIENTS ADMITTED TO THE COMMUNITY HOSPITALS OUT OF HOURS

PROCEDURE FOR MEDICINES RECONCILIATION BY NURSING STAFF FOR PATIENTS ADMITTED TO THE COMMUNITY HOSPITALS OUT OF HOURS PROCEDURE FOR MEDICINES RECONCILIATION BY NURSING STAFF FOR PATIENTS ADMITTED TO THE COMMUNITY HOSPITALS OUT OF HOURS Policy Details NHFT document reference MMPr030 Version 22/02/16 Date Ratified May 2016

More information

MEDICATION POLICY FOR DOMICILIARY CARE IN CEREDIGION

MEDICATION POLICY FOR DOMICILIARY CARE IN CEREDIGION MEDICATION POLICY FOR DOMICILIARY CARE IN CEREDIGION Authors Ceredigion Social Services Ceredigion Local Health Board Date of publication Review Date Final Version 1 01.12.08 LOGOS 1 1. INTRODUCTION These

More information

Procedures for the Prescribing Recording and Administration of Medicines

Procedures for the Prescribing Recording and Administration of Medicines The Newcastle Upon Tyne Hospitals NHS Trust Procedures for the Prescribing Recording and Administration of Medicines SIXTH EDITION January 2006 The Prescribing, Recording and Administration of Medicines

More information

Five Rights of Medication

Five Rights of Medication Five Rights of Medication Lack of knowledge has been implicated in many medication errors; therefore, education about broadly stated goals and practices to safely administer medications is essential. Medication

More information

Procedures for Transcribing Prescribed Medications. on to a Medication Administration Record (MAR) or Medication Instruction Sheet (MIS) (Version 2)

Procedures for Transcribing Prescribed Medications. on to a Medication Administration Record (MAR) or Medication Instruction Sheet (MIS) (Version 2) Procedures for Transcribing Prescribed Medications on to a Medication Administration Record (MAR) or Medication Instruction Sheet (MIS) (Version 2) CLINICAL GUIDELINES ID TAG: CG0079 Title: Procedures

More information

PROCESS FOR INITIATING A SYRINGE DRIVER FOR COMMUNITY NURSE PATIENTS OUT OF HOURS

PROCESS FOR INITIATING A SYRINGE DRIVER FOR COMMUNITY NURSE PATIENTS OUT OF HOURS STANDARD OPERATING PROCEDURE PROCESS FOR INITIATING A SYRINGE DRIVER FOR COMMUNITY NURSE PATIENTS OUT OF HOURS Issue History Issue Version one Purpose of Issue/Description of Change To facilitate patients

More information

POLICY FOR ANTICIPATORY PRESCRIBING FOR PATIENTS WITH A TERMINAL ILLNESS Just in Case

POLICY FOR ANTICIPATORY PRESCRIBING FOR PATIENTS WITH A TERMINAL ILLNESS Just in Case POLICY FOR ANTICIPATORY PRESCRIBING FOR PATIENTS WITH A TERMINAL ILLNESS Just in Case DOCUMENT NO: DN116 Lead author/initiator(s): Sarah Woodley Community Health Services Pharmacist sarah.woodley@ccs.nhs.uk

More information

Martina Khundakar - Senior Clinical Pharmacist Teresa Barnes - Lead Clinical Pharmacist - Specialist Care. Timothy Donaldson, Trust Chief Pharmacist

Martina Khundakar - Senior Clinical Pharmacist Teresa Barnes - Lead Clinical Pharmacist - Specialist Care. Timothy Donaldson, Trust Chief Pharmacist Policy on Pharmacological Therapies Practice Guidance Note The use of Oral Anti-Cancer Medicines and Oral Methotrexate within - V03 V03 - Issued Issue 1 Dec 15 Planned review December 2018 PPT-PGN 09 Part

More information

Document ref. no: Trust Policy and Procedure PP(16)238 MANAGEMENT OF ADULT PATIENTS TREATED WITH ORAL ANTICOAGULANTS. Approved

Document ref. no: Trust Policy and Procedure PP(16)238 MANAGEMENT OF ADULT PATIENTS TREATED WITH ORAL ANTICOAGULANTS. Approved Document ref. no: Trust Policy and Procedure PP(16)238 MANAGEMENT OF ADULT PATIENTS TREATED WITH ORAL ANTICOAGULANTS For use in: For use by: For use for: Document owner: Status: West Suffolk NHS Foundation

More information

Clinical Documentation Audit Tool for Continuing Healthcare Teams

Clinical Documentation Audit Tool for Continuing Healthcare Teams Action Clinical Documentation Audit Tool for Continuing Healthcare Teams This audit tool has been devised to monitor the standard of documentation at a local level and form a basis for discussion, measurement

More information

Community Clinics Policy and Procedure Manual C - 9 WARFARIN ADJUSTMENT PROTOCOL SUBJECT: WARFARIN ADJUSTMENT PROTOCOL

Community Clinics Policy and Procedure Manual C - 9 WARFARIN ADJUSTMENT PROTOCOL SUBJECT: WARFARIN ADJUSTMENT PROTOCOL Community Clinics Policy and Procedure Manual C - 9 SUBJECT: WARFARIN ADJUSTMENT PROTOCOL SUBJECT: WARFARIN ADJUSTMENT PROTOCOL APPROVED BY: VP Acute & Long Term Care & COO (South) EFFECTIVE DATE: 2007

More information

Uncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE. SECTION 9(a) UNLICENSED MEDICINES

Uncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE. SECTION 9(a) UNLICENSED MEDICINES Uncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE SECTION 9(a) UNLICENSED MEDICINES BACKGROUND and PURPOSE Under the Medicines Act 1968 (EEC Directive 65/65), a company

More information

KINGSTON GENERAL HOSPITAL NURSING POLICY & PROCEDURE

KINGSTON GENERAL HOSPITAL NURSING POLICY & PROCEDURE KINGSTON GENERAL HOSPITAL NURSING POLICY & PROCEDURE SUBJECT Documentation - Medication NUMBER PAGE 1 of 7 ORIGINAL ISSUE 1985 April REVIEW REVISION 2014 May Policy: 1. A standardized documentation process

More information

ADMINISTRATION OF MEDICINES POLICY

ADMINISTRATION OF MEDICINES POLICY ADMINISTRATION OF MEDICINES POLICY INTRODUCTION 1. This policy sets out the basis on which the school may agree to administer medicines to students. It is based on the March 2008 guidance document from

More information

Name Job Title Signed Date. This Patient Group Direction is operational from: Oct 2017 Review date: Aug 19. Expires on 31 st October 2019

Name Job Title Signed Date. This Patient Group Direction is operational from: Oct 2017 Review date: Aug 19. Expires on 31 st October 2019 PGD4017 PATIENT GROUP DIRECTION FOR THE SUPPLY OF ACICLOVIR TABLETS FOR THE TREATMENT OF GENITAL HERPES SIMPLEX INFECTIONS by registered nurses and midwives in Integrated Sexual Health services employed

More information

Alert. Patient safety alert. Actions that can make anticoagulant therapy safer. 28 March Action for the NHS and the independent sector

Alert. Patient safety alert. Actions that can make anticoagulant therapy safer. 28 March Action for the NHS and the independent sector Patient safety alert 18 Alert 28 March 2007 Immediate action Action Update Information request Ref: NPSA/2007/18 Actions that can make anticoagulant therapy safer Anticoagulants are one of the classes

More information

Procedure to Allow Nursing Staff to Dispense Leave and Discharge Medication

Procedure to Allow Nursing Staff to Dispense Leave and Discharge Medication Procedure to Allow Nursing Staff to Dispense Leave and Discharge Medication Version 2 minor update June 2013 Procedure Number Replaces Policy No. Ratifying Committee N/a PPPF Date Ratified April 2009 Minor

More information

NHS GREATER GLASGOW AND CLYDE POLICIES RELATING TO THE MANAGEMENT OF MEDICINES SECTION 9.1: UNLICENSED MEDICINES POLICY (ACUTE DIVISION)

NHS GREATER GLASGOW AND CLYDE POLICIES RELATING TO THE MANAGEMENT OF MEDICINES SECTION 9.1: UNLICENSED MEDICINES POLICY (ACUTE DIVISION) SECTION 9.1: UNLICENSED MEDICINES POLICY (ACUTE DIVISION) CONTENTS POLICY SUMMARY... 2 1. SCOPE... 4 2. AIM... 4 3. BACKGROUND... 4 4. POLICY STATEMENTS... 5 4.1. GENERAL STATEMENTS... 5 4.2 UNLICENSED

More information

New v1.0 Date: Cathy Riley - Director of Pharmacy Policy and Procedures Committee Policy and Procedures Committee

New v1.0 Date: Cathy Riley - Director of Pharmacy Policy and Procedures Committee Policy and Procedures Committee Clinical Pharmacy Services: SOP Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation Date: Review Date: Key Words:

More information

BEST PRACTICE GUIDANCE-SUPPLEMENTARY PRESCRIBING

BEST PRACTICE GUIDANCE-SUPPLEMENTARY PRESCRIBING BEST PRACTICE GUIDANCE-SUPPLEMENTARY PRESCRIBING NON MEDICAL PRESCRIBING ADVISOR IMPLEMENTATION DATE: MAY 2009 REVIEW DATE: MAY 2010 Supplementary Prescribing The working definition of supplementary prescribing

More information

Section 2 Medication Orders

Section 2 Medication Orders Section 2 Medication Orders 2-1 Objectives: 1. List/recognize the components of a complete medication order. 2. Transcribe orders onto the Medication Administration Record (MAR) correctly use proper abbreviations,

More information

Nurse prescribing in substance misuse February 2005, updated May 2005

Nurse prescribing in substance misuse February 2005, updated May 2005 Nurse prescribing in substance misuse February 2005, updated May 2005 1. Introduction This briefing aims to clarify the current situation in relation to nurse prescribing in the substance misuse sector.

More information

Policy for Patient Identification. Controlled Document Number: Version Number: 3 Controlled Document Sponsor: Controlled Document Lead:

Policy for Patient Identification. Controlled Document Number: Version Number: 3 Controlled Document Sponsor: Controlled Document Lead: CONTROLLED DOCUMENT Policy for Patient Identification CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Version Number: 3 Controlled Document Sponsor: Controlled Document Lead: Approved By:

More information

Guidance Notes for Endowment Research Grants

Guidance Notes for Endowment Research Grants NOTE: In this guidance document the numbering corresponds to the numbering of the application form for endowment grants APPLICATIONS AND CONDITIONS OF GRANT Value of funding Applications should be for

More information

MEDICATION RISK ASSESSMENT AND AGREEMENT FORM. Service User Name: Date: Service: SSID

MEDICATION RISK ASSESSMENT AND AGREEMENT FORM. Service User Name: Date: Service: SSID MEDICATION RISK ASSESSMENT AND AGREEMENT FORM Service User Name: Date: Service: SSID POSSIBLE RISK Is the service user able to order and collect prescriptions if needed? Can service user provide a list

More information

Anti-Coagulation Monitoring (warfarin, acenocoumarol, phenindione) Primary Care Service (PCS:01) NHS Standard Contract Service Profile Pack ( )

Anti-Coagulation Monitoring (warfarin, acenocoumarol, phenindione) Primary Care Service (PCS:01) NHS Standard Contract Service Profile Pack ( ) Anti-Coagulation Monitoring (warfarin, acenocoumarol, phenindione) Primary Care Service (PCS:01) This pack contains: Standard Contract Service Profile Pack () 1. Service Specification: (to be inserted

More information

Procedure 26 Standard Operating Procedure for Controlled Drugs in homes within NHS Sutton CCG

Procedure 26 Standard Operating Procedure for Controlled Drugs in homes within NHS Sutton CCG Standard Operating Procedure for Controlled Drugs in homes within NHS Sutton CCG Introduction All health and social care organisations are accountable for ensuring the safe management of controlled drugs

More information

Prescribing Lactoferrin in the ELFIN Clinical trial

Prescribing Lactoferrin in the ELFIN Clinical trial Prescribing Lactoferrin in the ELFIN Clinical trial PAULA JENKINS RESEARCH NURSE NPEU Why Lactoferrin is deemed an Investigational Medicinal Product any substance or combination of substances presented

More information

SafetyFirst Alert. Improving Prescription/Order Writing. Illegible handwriting

SafetyFirst Alert. Improving Prescription/Order Writing. Illegible handwriting SafetyFirst Alert Massachusetts Coalition for the Prevention of Medical Errors January 2000 This issue of Safety First Alert is a publication of the Massachusetts Coalition for the Prevention of Medical

More information

Policy Statement Medication Order Legibility Medication orders will be written in a manner that provides a clearly legible prescription.

Policy Statement Medication Order Legibility Medication orders will be written in a manner that provides a clearly legible prescription. POLICY POLICY PURPOSE: The purpose of this policy is to provide a foundation for safe communication of medication and nutritional orders in-scope, thereby reducing the potential for preventable medication

More information

National Emergency Medicine Programme. Protocol for the administration of Paracetamol (Acetaminophen) at Triage in the Emergency Department

National Emergency Medicine Programme. Protocol for the administration of Paracetamol (Acetaminophen) at Triage in the Emergency Department National Emergency Medicine Programme Protocol for the administration of Paracetamol (Acetaminophen) at Triage in the Emergency Date: November 2016 Table of Contents 1.0 Critical Elements... 3 2.0 Clinical

More information

RESUSCITATION/DO NOT ATTEMPT RESUSCITATION (DNAR) POLICY

RESUSCITATION/DO NOT ATTEMPT RESUSCITATION (DNAR) POLICY Appendix 9 RESUSCITATION/DO NOT ATTEMPT RESUSCITATION (DNAR) POLICY Approval Committee Version Issue Date Review Date Document Author GaRMC TMB Final January 2011 January 2012 Resuscitation Committee Author:

More information

Omitted and Delayed Medicines

Omitted and Delayed Medicines pecialist Pharmacy ervice Medicines Use and afety Omitted and Delayed Medicines A collaborative audit of omitted and delayed anti-microbial in acute, community and mental health settings Jane Hough and

More information

Do Not Attempt Cardiopulmonary Resuscitation (DNACPR) Policy

Do Not Attempt Cardiopulmonary Resuscitation (DNACPR) Policy Do Not Attempt Cardiopulmonary Resuscitation (DNACPR) Policy 1 Policy Title: Executive Summary: Do Not Attempt Cardiopulmonary Resuscitation (DNACPR) Policy Cardiopulmonary resuscitation (CPR) can be attempted

More information

METHOTREXATE TOXICITY

METHOTREXATE TOXICITY METHOTREXATE TOXICITY AN INQUIRY INTO THE DEATH OF A CAMBRIDGESHIRE PATIENT IN APRIL 2000 CAMBRIDGESHIRE HEALTH AUTHORITY JULY 2000 CONTENTS PAGE 1 Introduction 2 2 Background 2 3 Context 2 4 Purpose of

More information

Aneurin Bevan University Health Board Clinical Record Keeping Policy

Aneurin Bevan University Health Board Clinical Record Keeping Policy N.B. Staff should be discouraged from printing this document. This is to avoid the risk of out of date printed versions of the document. The Intranet should be referred to for the current version of the

More information

PHARMACIST AMENDMENT OF PRESCRIBING REGIMENS AND COMPILING LISTS OF TAKE HOME MEDICATION POLICY AND PROCEDURE

PHARMACIST AMENDMENT OF PRESCRIBING REGIMENS AND COMPILING LISTS OF TAKE HOME MEDICATION POLICY AND PROCEDURE Wirral University Teaching Hospital NHS Foundation Trust Policy / Procedure Reference: 045j PHARMACIST AMENDMENT OF PRESCRIBING REGIMENS AND COMPILING LISTS OF TAKE HOME MEDICATION POLICY AND PROCEDURE

More information

Trial Management: Trial Master Files and Investigator Site Files

Trial Management: Trial Master Files and Investigator Site Files Title: Outcome Statement: Written By: Trial Management: Trial Master Files and Investigator Site Files Staff working on research studies in NSFT will be informed about the requirements of setting up and

More information

PROCEDURE FOR RECORD KEEPING FOR HEALTH VISITING

PROCEDURE FOR RECORD KEEPING FOR HEALTH VISITING PROCEDURE FOR RECORD KEEPING FOR HEALTH VISITING Issue History Issue Version One Purpose of Issue/Description of Change Planned Review Date To promote safe and effective record keeping for all staff working

More information

Protocol Applies To: UW Health Clinics: all adult outpatients with an active order for warfarin

Protocol Applies To: UW Health Clinics: all adult outpatients with an active order for warfarin Protocol Number: 7 Protocol Title: Ambulatory Initiation and Management of Warfarin for Adults Protocol Applies To: UW Health Clinics: all adult outpatients with an active order for warfarin Target Patient

More information

PROCEDURE FOR RECORD KEEPING, TEAM DIARY AND CASE LOAD MANAGEMENT

PROCEDURE FOR RECORD KEEPING, TEAM DIARY AND CASE LOAD MANAGEMENT PROCEDURE FOR RECORD KEEPING, TEAM DIARY AND CASE LOAD MANAGEMENT APPLICABLE FOR:- COMMUNITY NURSING COMMUNITY MATRONS WIRRAL ADMISSION PREVENTION SERVICE SPECIALIST NURSES WORKING IN COMMUNITY SETTING

More information

POLICY ON NURSE PRESCRIBING IN OLCHC EDITION 6

POLICY ON NURSE PRESCRIBING IN OLCHC EDITION 6 POLICY ON NURSE PRESCRIBING IN OLCHC EDITION 6 Version Number 6 Date of Issue 23 rd December 2015 Reference Number Review Interval Approved By Name: Rachel Kenna Title: Director of Nursing Title: Drugs

More information

Advance Statement / Wishes What I would like to happen to me if I become unwell

Advance Statement / Wishes What I would like to happen to me if I become unwell USEFUL INFORMATION/CONTACTS Making Decisions - A Guide Information booklets about the Mental Capacity Act (2005) Tel. 02380 878038 www.dca.gov.uk/legal-policy/mental-capacity/mibooklets/ booklet01.pdf

More information

ADULT SEPSIS SCREEN & BUNDLE (INCLUDING NEUTROPENIC GUIDELINES) FOR ESSENTIAL FIRST HOUR MANAGEMENT GUIDE

ADULT SEPSIS SCREEN & BUNDLE (INCLUDING NEUTROPENIC GUIDELINES) FOR ESSENTIAL FIRST HOUR MANAGEMENT GUIDE Title: Directorate: Responsible for review: Ratified by: ADULT SEPSIS SCREEN & BUNDLE (INCLUDING NEUTROPENIC GUIDELINES) FOR ESSENTIAL FIRST HOUR MANAGEMENT GUIDE Organisation Wide Patient Safety Lead

More information

Homecare Medicines Charter

Homecare Medicines Charter Purpose of this charter Homecare Medicines Charter The purpose of this charter is to provide you with information on homecare medicines services. It will include the steps you will go through and what

More information

MEDICAL CONDITIONS AND MEDICATION POLICY

MEDICAL CONDITIONS AND MEDICATION POLICY Round Oak School, Support Service & Sports College MEDICAL CONDITIONS AND MEDICATION POLICY Reviewed: June 2013 Next Review: Summer 2016 (unless it is necessary to be revised sooner) Reviewed: Autumn 2016

More information

Patient Group Direction for Aspirin 300mg Version: 02 Start Date: 1 st October 2017 Expiry Date: 30 th September 2019

Patient Group Direction for Aspirin 300mg Version: 02 Start Date: 1 st October 2017 Expiry Date: 30 th September 2019 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS: CLINICAL COMMISSIONING GROUP: Doncaster CCG, Lancashire CCGs including East Lancashire, Fylde and Wyre and North Lancashire

More information

To contact us please

To contact us please Issue 13, June 2015 Newsletter for Care Home staff, General Practitioners and Community Pharmacists The Caring for Care Homes team produced The Medicines Management Checklist in 2010 to provide care homes

More information

Medical Needs Policy. Policy Date: March 2017

Medical Needs Policy. Policy Date: March 2017 Medical Needs Policy Policy Date: March 2017 Renewal Date: March 2017 Equality Statement This policy takes into account the provisions of the Equality Act 2010 and advances equal opportunities for all.

More information

Guidelines for the Self-administration of In-Patients Own Medicines

Guidelines for the Self-administration of In-Patients Own Medicines Guidelines for the Self-administration of In-Patients Own Medicines Version Date Of Reviewer Completed Approved Date New Review No: Review: Name: Action: by: Approved: Date: 1.0 1.11.2016 Brief Summary

More information

Protocol for Patients on oral Anticoagulants who wish to perform INR self testing. Anticoagulation service Bolton NHS Foundation Trust. April 2017.

Protocol for Patients on oral Anticoagulants who wish to perform INR self testing. Anticoagulation service Bolton NHS Foundation Trust. April 2017. Protocol for Patients on oral Anticoagulants who Anticoagulation service Bolton NHS Foundation Trust April 2017. Document Control Document Ref No. ANTICO05 Title of document Protocol for Patient s on oral

More information

Moving the Green Medicines Bag from the Safety Agenda to QIPP

Moving the Green Medicines Bag from the Safety Agenda to QIPP Moving the Green Medicines Bag from the Safety Agenda to QIPP Jane Hough (ESEE Specialist Pharmacy Services) Fiona Eccleston (PSF Project Manager) Ed England ( Ambulance Service) Facts and figures 97%

More information

Audit Data Collection Form

Audit Data Collection Form pecialist Pharmacy ervice Medicines Use and afety Audit Data Collection Form Collaborative audit across England on the quality of medication related information provided when transferring patients from

More information

ADMITTING YOUNG PEOPLE UNDER 18 TO ADULT MENTAL HEALTH WARDS POLICY

ADMITTING YOUNG PEOPLE UNDER 18 TO ADULT MENTAL HEALTH WARDS POLICY ADMITTING YOUNG PEOPLE UNDER 18 TO ADULT MENTAL HEALTH WARDS POLICY Version: 2 Ratified By: Date Ratified: August 2015 Title of Originator/Author Title of Responsible Committee/Group Senior Managers Operational

More information

MAR/MEDICATION AUDIT NAME NAME NAME

MAR/MEDICATION AUDIT NAME NAME NAME MAR/MEDICATION AUDIT NAME NAME NAME DATE Copies of all current prescriptions in file (correlate with MAR, Meds on hand and Healthcare Communication Forms) MAR reflects current correct medications, correct

More information

Non-Medical Prescribing Passport. Reflective Log And Information

Non-Medical Prescribing Passport. Reflective Log And Information Non-Medical Prescribing Passport Reflective Log And Information Non-Medical Prescribing Continued Profession Development Log NMPs must refer to their regulatory bodies requirements for maintaining and

More information

NHS Lanarkshire Policy for the Availability of Unlicensed Medicines

NHS Lanarkshire Policy for the Availability of Unlicensed Medicines NHS Lanarkshire Policy for the Availability of Unlicensed Medicines Prepared by: NHS Lanarkshire Chief Pharmacist Endorsed by: Area Drug & Therapeutic Committee Previous Version/Date: Primary Policy Date:

More information

STUDENT PERSONNEL MEDICATION POLICY ADMINISTRATIVE PROCEDURES

STUDENT PERSONNEL MEDICATION POLICY ADMINISTRATIVE PROCEDURES STUDENT PERSONNEL MEDICATION POLICY ADMINISTRATIVE PROCEDURES Procedures for Implementation of Medication Administration A. All administration of medication must be under the general supervision of a Licensed

More information

Medicines Management in the Domiciliary Setting (Adults) Policy

Medicines Management in the Domiciliary Setting (Adults) Policy Policy Author: Sponsor/Executive: Responsible committee: Ratified by: Consultation & Approval: (Committee/Groups which signed off the policy, including date) This document replaces: Original author Principal

More information

Anticoagulation: Safe prescribing, dispensing and administration of oral and parenteral anticoagulants

Anticoagulation: Safe prescribing, dispensing and administration of oral and parenteral anticoagulants Trust Policy Anticoagulation: Safe prescribing, dispensing and administration of oral and parenteral anticoagulants Purpose Date Version March 2015 2 To manage the inherent risks to patients from the use

More information

MIDWIFE AND HEALTH VISITOR COMMUNICATION PROCEDURE

MIDWIFE AND HEALTH VISITOR COMMUNICATION PROCEDURE Appendix 2a of the Health Visiting Overarching Policy MIDWIFE AND HEALTH VISITOR COMMUNICATION PROCEDURE 1. Introduction 1.1. This procedure sets out standards of best practice regarding communication

More information

POLICY FOR THE IMPLEMENTATION OF SECTION 132 OF THE MENTAL HEALTH ACT (MHA) 1983 AS AMENDED BY THE MHA 2007:

POLICY FOR THE IMPLEMENTATION OF SECTION 132 OF THE MENTAL HEALTH ACT (MHA) 1983 AS AMENDED BY THE MHA 2007: POLICY FOR THE IMPLEMENTATION OF SECTION 132 OF THE MENTAL HEALTH ACT (MHA) 1983 AS AMENDED BY THE MHA 2007: PROVISION OF INFORMATION TO DETAINED PATIENTS Document Author Written By: Lead for Mental Health

More information

Camden Clinical Commissioning Group Reporting Mechanism/Frequency Remotely/Quarterly

Camden Clinical Commissioning Group Reporting Mechanism/Frequency Remotely/Quarterly Universal Offer Service Anticoagulation - Warfarin Clinical Lead Dr Kevan Ritchie Commissioner Camden Clinical Commissioning Group Reporting Mechanism/Frequency Remotely/Quarterly Payment Frequency Quarterly

More information

Unlicensed Medicines Policy

Unlicensed Medicines Policy Unlicensed Medicines Policy This procedural document supersedes: PAT/MM 4 v.3 Policy and Procedure for the Use of Unlicensed Medicines Did you print this document yourself? The Trust discourages the retention

More information

Advance Decision to Refuse Treatment (ADRT) Policy

Advance Decision to Refuse Treatment (ADRT) Policy Advance Decision to Refuse Treatment (ADRT) Policy This procedural document supersedes: PAT/PA 27 v.1 - POLICY FOR THE MANAGEMENT OF ADVANCE DECISION TO REFUSE TREATMENT (ADRT) Did you print this document

More information

Lithium: Policy for the Safe Initiation, Prescribing, Dispensing and Monitoring of Lithium Preparations. Version No 2.2.

Lithium: Policy for the Safe Initiation, Prescribing, Dispensing and Monitoring of Lithium Preparations. Version No 2.2. Livewell Southwest Lithium: Policy for the Safe Initiation, Prescribing, Dispensing and Monitoring of Lithium Preparations Version No 2.2 Review: May 2019 Notice to staff using a paper copy of this guidance

More information

Grampian University Hospitals NHS Trust. Local Report ~ February Older People in Acute Care

Grampian University Hospitals NHS Trust. Local Report ~ February Older People in Acute Care Grampian University Hospitals NHS Trust Local Report ~ February 2004 Older People in Acute Care NHSScotland Board Areas 13 12 15 1 Argyll & Clyde 2 Ayrshire & Arran 3 Borders 9 7 4 Dumfries & Galloway

More information

Section 9. Study Product Considerations for Non- Pharmacy Staff

Section 9. Study Product Considerations for Non- Pharmacy Staff Section 9. Study Product Considerations for Non- Pharmacy Staff Table of Contents 9.1 Dispensing Study Product 9.1.1 Chain of Custody 9.1.2 Initial Vaginal Ring Dispensing(s)- Prescription Overview 9.2

More information

Pharmacy Department Orientation

Pharmacy Department Orientation Pharmacy Department Orientation June 26, 2015 Brittany N. White, PharmD, BCPS Pharmacy Ext. 7238 Main Pharmacy Department Located on the 6 th floor Open 24 hours a day 7 days a week Children s Located

More information

EMERGENCY CARE DISCHARGE SUMMARY

EMERGENCY CARE DISCHARGE SUMMARY EMERGENCY CARE DISCHARGE SUMMARY IMPLEMENTATION GUIDANCE JUNE 2017 Guidance for implementation This section sets out issues identified during the project which relate to implementation of the headings.

More information

Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1

Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1 Managing medicines in care homes Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information